SIGA Technologies Stock Discussion

Pharmaceutical Technology Company Secures $113 Million U.S. Government Order
SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company, has recently announced that the U.S. Department of Health and Human Services (HHS) has exercised a procurement option, resulting in an order worth approximately $113 million for oral TPOXX® treatment courses. $SIGA Technologies(SIGA.US)$
https://stockregion.app/p/pharmaceutical-technology-company

$Calidi Biotherapeutics(CLDI.US)$ $SIGA Technologies(SIGA.US)$ Calidi Biotherapeutics Collaborates With SIGA Technologies to Advance Calidi’s Revolutionary Rtnova Virotherapy for Lung Cancer and Metastatic Solid Tumors

$SIGA Technologies(SIGA.US)$ they are still not telling full story ! interesting

SIGA Technologies Inc Announces a Special Dividend: What it Means for Shareholders.
In a recent announcement that has stirred the world of biotechnology and pharmaceuticals, SIGA Technologies Inc., an American company known for its groundbreaking work in the development and commercialization of solutions for serious unmet medical needs and biothreats, has declared a special cash dividend of $0.60 per share. $SIGA Technologies(SIGA.US)$
...

$SIGA Technologies(SIGA.US)$ shares went up 8.3% to $5.76 in post-market trading on 12 Mar (Tuesday( after it reported profit in its Q4 earnings on a surge in revenue and a 60 cents special cash dividend was announced.
SIGA reported a net profit of $72.3 million, or $1.01 a share, compared with a loss of $800,000, or 1 cent a share, for the same period a year earlier. Product revenue surged to $115.7 million from $5.1 million a year ago, tak...